Clinical and Translational Oncology

, Volume 18, Issue 4, pp 381–384 | Cite as

Short stature in retinoblastoma survivors: a cross-sectional study of 138 patients

Research Article
First Online:
Received:
Accepted:
  • 72 Downloads

Abstract

Purpose

Short stature has been reported in pediatric cancer survivors. Data on retinoblastoma survivors are limited. We conducted a cross-sectional study to assess the height in retinoblastoma survivors.

Method

The recorded height was compared with median height for age and sex as per the Indian Academy of Pediatrics. Z-score less than −2 was considered short statured.

Result

Thirty percent of the survivors were short statured. The mean height was shorter than the mean 50th percentile height (119.7 ± 14.8 vs 128.7 ± 15 cm, p < 0.001). Previous chemotherapy showed a trend toward association (p = 0.09).

Conclusion

Short stature affects a significant number of retinoblastoma survivors.

Keywords

Short stature Retinoblastoma Long-term effects Survivorship 
This is a preview of subscription content, log in to check access.

Notes

Compliance with ethical standards

Conflict of interest

None.

References

  1. 1.
    Houston SK, Murray TG, Wolfe SQ, Fernandes CE. Current update on retinoblastoma. Int Ophthalmol Clin. 2011;51:77–91.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Smith M, Hare ML. An overview of progress in childhood cancer survival. J Pediatr Oncol Nurs Off J Assoc Pediatr Oncol Nurses. 2004;21:160–4.CrossRefGoogle Scholar
  3. 3.
    Chow EJ, Friedman DL, Yasui Y, Whitton JA, Stovall M, Robison LL, et al. Decreased adult height in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Pediatr. 2007;150:370–5.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Birkebaek NH, Clausen N. Height and weight pattern up to 20 years after treatment for acute lymphoblastic leukaemia. Arch Dis Child. 1998;79:161–4.CrossRefPubMedGoogle Scholar
  5. 5.
    Clayton PE, Shalet SM, Morris-Jones PH, Price DA. Growth in children treated for acute lymphoblastic leukaemia. Lancet. 1988;1:460–2.CrossRefPubMedGoogle Scholar
  6. 6.
    Bongers MEJ, Francken AB, Rouwé C, Kamps WA, Postma A. Reduction of adult height in childhood acute lymphoblastic leukemia survivors after prophylactic cranial irradiation. Pediatr Blood Cancer. 2005;45:139–43.CrossRefPubMedGoogle Scholar
  7. 7.
    Van der Does-van den Berg A, de Vaan GA, van Weerden JF, Hählen K, van Weel-Sipman M, Veerman AJ. Late effects among long-term survivors of childhood acute leukemia in The Netherlands: a Dutch Childhood Leukemia Study Group Report. Pediatr Res. 1995;38:802–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Noorda EM, Somers R, van Leeuwen FE, Vulsma T, Behrendt H. Adult height and age at menarche in childhood cancer survivors. Eur J Cancer. 2001;37:605–12.CrossRefPubMedGoogle Scholar
  9. 9.
    Shalitin S, Laur E, Lebenthal Y, Ash S, Yaniv I, Phillip M. Endocrine complications and components of the metabolic syndrome in survivors of childhood malignant non-brain solid tumors. Horm Res Pædiatrics. 2014;81:32–42.CrossRefGoogle Scholar
  10. 10.
    Gurney JG, Ness KK, Stovall M, Wolden S, Punyko JA, Neglia JP, et al. Final height and body mass index among adult survivors of childhood brain cancer: childhood cancer survivor study. J Clin Endocrinol Metab. 2003;88:4731–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Friedman DN, Sklar CA, Oeffinger KC, Kernan NA, Khakoo Y, Marr BP, et al. Long-term medical outcomes in survivors of extra-ocular retinoblastoma: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience. Pediatr Blood Cancer. 2013;60:694–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Khadilkar V, Yadav S, Agrawal KK, Tamboli S, Banerjee M, Cherian A, et al. Revised IAP growth charts for height, weight and body mass index for 5- to 18-year-old Indian children. Indian Pediatr. 2015;52:47–55.CrossRefPubMedGoogle Scholar
  13. 13.
    Shalitin S, Laur E, Lebenthal Y, Ash S, Yaniv I, Phillip M. Endocrine complications and components of the metabolic syndrome in survivors of childhood malignant non-brain solid tumors. Horm Res Pædiatrics. 2014;81:32–42.CrossRefGoogle Scholar
  14. 14.
    Schell MJ, Ochs JJ, Schriock EA, Carter M. A method of predicting adult height and obesity in long-term survivors of childhood acute lymphoblastic leukemia. J Clin Oncol Off J Am Soc Clin Oncol. 1992;10:128–33.Google Scholar
  15. 15.
    Shalitin S, Gal M, Goshen Y, Cohen I, Yaniv I, Phillip M. Endocrine outcome in long-term survivors of childhood brain tumors. Horm Res Pædiatrics. 2011;76:113–22.CrossRefGoogle Scholar
  16. 16.
    Schriock EA, Schell MJ, Carter M, Hustu O, Ochs JJ. Abnormal growth patterns and adult short stature in 115 long-term survivors of childhood leukemia. J Clin Oncol Off J Am Soc Clin Oncol. 1991;9:400–5.Google Scholar
  17. 17.
    Schell MJ, Ochs JJ, Schriock EA, Carter M. A method of predicting adult height and obesity in long-term survivors of childhood acute lymphoblastic leukemia. J Clin Oncol Off J Am Soc Clin Oncol. 1992;10:128–33.Google Scholar
  18. 18.
    Ochs J, Mulhern R. Long-term sequelae of therapy for childhood acute lymphoblastic leukaemia. Baillières Clin Haematol. 1994;72:365–76.CrossRefGoogle Scholar
  19. 19.
    Hokken-Koelega AC, van Doorn JW, Hählen K, Stijnen T, de Muinck Keizer-Schrama SM, Drop SL. Long-term effects of treatment for acute lymphoblastic leukemia with and without cranial irradiation on growth and puberty: a comparative study. Pediatr Res. 1993;33:577–82.CrossRefPubMedGoogle Scholar
  20. 20.
    Sklar C, Mertens A, Walter A, Mitchell D, Nesbit M, O’Leary M, et al. Final height after treatment for childhood acute lymphoblastic leukemia: comparison of no cranial irradiation with 1800 and 2400 centigrays of cranial irradiation. J Pediatr. 1993;123:59–64.CrossRefPubMedGoogle Scholar
  21. 21.
    Dalton VK, Rue M, Silverman LB, Gelber RD, Asselin BL, Barr RD, et al. Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment. J Clin Oncol. 2003;21:2953–60.CrossRefPubMedGoogle Scholar

Copyright information

© Federación de Sociedades Españolas de Oncología (FESEO) 2015

Authors and Affiliations

  1. 1.Department of Medical Oncology, Dr. B.R.A. Institute Rotary Cancer HospitalAll India Institute of Medical SciencesNew DelhiIndia

Personalised recommendations